The Varian Medical Systems Inc. (VAR) CFO Sold $461,525.16 in Stock

The Varian Medical Systems Inc. (VAR) CFO Sold $461,525.16 in Stock

Varian Medical Systems Inc. (NYSE:VAR) CFO Elisha W. Finney sold 4,668 shares of the firm’s stock in a transaction that occurred on Monday, October 3rd. The shares were sold at an average price of $98.87, for a total transaction of $461,525.16. Following the completion of the sale, the chief financial officer now owns 9,863 shares of the company’s stock, valued at $975,154.81. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

Varian Medical Systems Inc. (NYSE:VAR) opened at 99.02 on Monday. The company’s 50 day moving average is $96.79 and its 200 day moving average is $87.79. Varian Medical Systems Inc. has a one year low of $73.18 and a one year high of $100.07. The stock has a market cap of $9.25 billion, a PE ratio of 25.13 and a beta of 0.71.

Varian Medical Systems (NYSE:VAR) last announced its quarterly earnings data on Wednesday, July 27th. The company reported $1.22 EPS for the quarter, beating the Zacks’ consensus estimate of $1.17 by $0.05. Varian Medical Systems had a net margin of 12.28% and a return on equity of 25.01%. The company had revenue of $789.40 million for the quarter, compared to the consensus estimate of $779.90 million. During the same period in the prior year, the firm posted $1.15 EPS. The company’s quarterly revenue was up .7% compared to the same quarter last year. On average, equities research analysts expect that Varian Medical Systems Inc. will post $4.64 EPS for the current year.

Several large investors have recently made changes to their positions in the stock. Los Angeles Capital Management & Equity Research Inc. increased its stake in shares of Varian Medical Systems by 43.5% in the first quarter. Los Angeles Capital Management & Equity Research Inc. now owns 23,428 shares of the company’s stock worth $1,875,000 after buying an additional 7,105 shares in the last quarter. FDO Partners LLC increased its stake in shares of Varian Medical Systems by 0.4% in the first quarter. FDO Partners LLC now owns 9,218 shares of the company’s stock worth $738,000 after buying an additional 35 shares in the last quarter. BlackRock Group LTD increased its stake in shares of Varian Medical Systems by 8.0% in the first quarter. BlackRock Group LTD now owns 976,124 shares of the company’s stock worth $78,109,000 after buying an additional 71,933 shares in the last quarter. BlackRock Fund Advisors increased its stake in shares of Varian Medical Systems by 10.7% in the first quarter. BlackRock Fund Advisors now owns 2,826,016 shares of the company’s stock worth $226,138,000 after buying an additional 272,924 shares in the last quarter. Finally, JPMorgan Chase & Co. increased its stake in shares of Varian Medical Systems by 43.4% in the first quarter. JPMorgan Chase & Co. now owns 59,346 shares of the company’s stock worth $4,748,000 after buying an additional 17,966 shares in the last quarter. 99.65% of the stock is currently owned by institutional investors.

Several equities research analysts have recently commented on VAR shares. Morgan Stanley lifted their price objective on shares of Varian Medical Systems from $80.00 to $86.00 and gave the stock an “underweight” rating in a research note on Thursday, July 28th. Brean Capital lifted their price objective on shares of Varian Medical Systems from $87.00 to $90.00 and gave the stock a “buy” rating in a research note on Thursday, July 28th. Jefferies Group reiterated a “buy” rating and set a $98.00 price objective on shares of Varian Medical Systems in a research note on Wednesday, September 28th. Zacks Investment Research downgraded shares of Varian Medical Systems from a “hold” rating to a “sell” rating in a research note on Wednesday, June 29th. Finally, Barrington Research lowered their price objective on shares of Varian Medical Systems from $102.00 to $93.00 and set an “outperform” rating for the company in a research note on Thursday, July 28th. One research analyst has rated the stock with a sell rating, five have given a hold rating and four have issued a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and an average target price of $91.33.

About Varian Medical Systems

Related posts

Leave a Comment